On February 19, within the discipline ‘Regulatory Support of Biotechnological Enterprises’ for third-year bachelors of the EP ‘Biotechnologies: Pharmaceutical, Industrial, Food, Environmental’ at the invitation of the lecture instructor Svitlana Starovoyeva, a guest lecture was held to deepen and develop hard skills from a practicing specialist with extensive experience Krasnoschok Liubov Mikhaylivna, a GxP expert at Arterium Corporation, on the topic ‘GMP – Features of Pharmaceutical Manufacturing’. Ms. Liubov has more than 40 years of practical experience in this field and graciously agreed to share her valuable experience and knowledge with our students.
At the beginning of the lecture, Marina Herasymenko, Training and Development Manager at Arterium Corporation, conducted an engaging survey for the students using the online service Mentimeter.
Subsequently, Ms. Liubov Krasnoschok completely captivated the students’ attention with her incredibly useful and interesting account of the features of pharmaceutical manufacturing and quality control in accordance with GMP requirements. In Ukraine, European GMP requirements are in effect. Issues concerning qualification and validation, as well as their main stages, were outlined. It was noted that international standards clearly define the frequency of requalification procedures. In accordance with current standards, requalification of clean rooms must be conducted once per year. The speaker drew particular attention to the mandatory nature of the documentation system. As the lecturer noted, there must be Standard Operating Procedures for Standard Operating Procedures. That is, in accordance with GMP requirements, it is mandatory to have documents that establish requirements and documents that confirm that the work was performed. And many more interesting facts were presented during Ms. Liubov’s lecture!
The students had just begun studying the discipline ‘Regulatory Support of Biotechnological Enterprises’, so familiarization with GMP requirements was a first-time experience for them, and here are some impressions from the information received from the students themselves:
Lytvyn Anastasiya (BT-3-2) “Today we had a guest lecture ‘Introduction to Arterium’, which was opened by Marina Herasymenko – Training and Development Manager at Arterium Corporation, who is engaged in youth development.
We began with a real-time survey where the statistics of answer options were tracked on screen through demonstration. There we discussed questions about whether we already had work experience, what is important to us when choosing an employer, whether we had heard of Arterium and what exactly we know about this corporation. The answers and statistics were diverse and interesting.
The lecture was then continued by Krasnoschok Liubov – a GxP expert, who conducted a course for us on the features of pharmaceutical manufacturing in the pharmaceutical industry.
In general, GMP is a set of proper conditions under which pharmaceutical products must be manufactured. If such conditions are created for production, then it can be guaranteed that the pharmaceutical product will be of high quality (meet all quality specification requirements), effective (effectively treat), and safe (manufacturer responsibility for consumer safety). GMP is the foundation, which is the basis for the entire pharmaceutical quality assurance system. After all, a pharmaceutical product is a special product, not just a product that can be consumed every day; it must be treated with care. Therefore, GMP includes two main processes: establishing requirements for the production of pharmaceutical products and controlling their quality. So we then examined in detail the main principles of GMP, namely: continuous improvement of the quality system, personnel and the role of the authorized quality person, proper premises, equipment and systems, documentation simplicity, manufacturing processes and validation, reliability and accuracy of quality control, interaction with partners, response to complaints and effective product recall, self-inspections.
In conclusion, I want to thank the speakers for such an informative lecture and interesting information. Each listener learned something useful and new for themselves, which makes us educated in our future specialty, since Arterium ‘Farms the Future’!”
Latushkin Oleksiy (BT-3-1): “When I was looking at various job vacancies and reading their descriptions on specialized resources, the greatest uncertainty for me was precisely the line ‘knowledge of GMP requirements’. Then I heard in passing that this is Good Manufacturing Practice, which provides a set of principles for pharmaceutical enterprises to ensure quality, but I couldn’t say anything specific. Fortunately, today our stream had a guest lecture from a practicing specialist, at which we were able to explain the main points of this system. We were told what GMP represents, what constitutes the provision of proper practice (equipment requirements, personnel, facilities, etc.), validation, continuous monitoring of raw materials, manufacturing process, outsourcing and more. Unfortunately, due to time constraints, it was not possible to fully deliver the lecture, but most of the material was covered, and students were provided with a presentation and the opportunity to ask questions to the lecturer via email. Overall, we can say that today’s event was very helpful for those planning to work at a pharmaceutical enterprise”
Ovcharenko Kateryna (BT-3-2): “On 02.19, during the lecture on regulatory support of biotechnological enterprises, representatives of ‘Arterium’ company visited our stream. The meeting started with an interactive session on the ‘Mentimeter’ platform, where we were able to answer questions about the corporation and the pharmaceutical industry in general. During the survey, I was very surprised that some of us had not heard of such a well-known pharmaceutical company in our market as ‘Arterium’. Then there was an open lecture dedicated to GMP standards, directly at the company. We were able to discuss the goals and objectives of the pharmaceutical company; the main principles of GMP and their improvement; proper premises, equipment and systems for supply in accordance with accepted standards; warehouse zone requirements; the difference between validation and qualification and many other interesting topics related to pharmacy. Personally, for me this lecture was useful both as a student and as a person interested in further work in the pharmaceutical market. The information was very interesting and fully revealed the content of the discussed topic, and the lecturer had an excellent command of the material and answered all questions posed to her”.
We are very grateful to Ms. Liubov Krasnoschok and Arterium Corporation for organizing professional lectures from practicing professionals!













